Sigachi Industries
58.43
+0.98(+1.71%)
Market Cap₹1,948.33 Cr
PE Ratio27.48
IndustryHealthcare
Company Performance:
1D+1.71%
1M+34.38%
6M+10.37%
1Y-9.68%
5Y-2.37%
View Company Insightsright
Latest news about Sigachi Industries
Sigachi Industries Secures Approval for New API and Specialty Chemicals Plant 1 day ago Yesterday
Sigachi Industries has received Terms of Reference (ToR) approval for a new manufacturing plant in Orvakal, Andhra Pradesh, focused on Active Pharmaceutical Ingredients (APIs) and specialty chemicals. This approval is a key step in the company's expansion strategy, potentially enhancing its market position and production capabilities. The project aligns with environmental regulations, suggesting a commitment to sustainable growth. Specific details about investment, capacity, and timelines are yet to be disclosed.
Sigachi Industries Reports Mixed Q4 Results: EBITDA Soars, Net Profit Dips May 30, 2025
Sigachi Industries Secures European Certification for Metformin Hydrochloride May 07, 2025
Sigachi Industries' Subsidiary Inks MoU with Respilon for Cutting-Edge Nanofiber Drug Delivery Technology Apr 28, 2025
Sigachi Industries Secures Environmental Clearance for Dahej 2 SEZ Facility, Paving Way for Expansion Apr 17, 2025
More news about Sigachi Industries
01Apr 25
Sigachi Industries' Stock Climbs 3.33% Amid Promoter Share Pledge and R&D Investment Plans
Sigachi Industries' stock price increased by 3.33% to ₹36.30 on Tuesday, despite overall weak market conditions. This rise occurred despite a recent share pledge by promoter Dharani Devi Chidambaranatham of 9,10,000 shares (0.23% equity). The company announced plans to invest $1 million in a new R&D center in Hyderabad, potentially boosting investor confidence in its growth strategy.
13Mar 25
Sigachi Industries Partners with Indian Navy for Health Initiative in Visakhapatnam
Sigachi Industries Limited has signed an MoU with INS Kalinga of the Indian Navy to launch an eight-month community fitness program in Visakhapatnam. The 'Vizag Navy Marathon Promo cum Conditioning Programme' will run from March to October 2025, featuring monthly events on the second Sunday. This partnership aims to promote health, wellness, and community engagement in the coastal city.
Sigachi Industries
58.43
+0.98
(+1.71%)
1 Year Returns:-9.68%
Industry Peers
Sun Pharmaceutical
1,687.80
(+0.02%)
Divis Laboratories
6,667.00
(-0.86%)
Cipla
1,505.20
(+0.16%)
Dr Reddys Laboratories
1,362.50
(-0.01%)
Torrent Pharmaceuticals
3,252.50
(-0.19%)
Mankind Pharma
2,381.30
(-0.36%)
Zydus Life Science
974.95
(-0.39%)
Lupin
1,999.60
(-1.17%)
Abbott
31,515.00
(-0.19%)
Aurobindo Pharma
1,150.20
(-0.43%)